MedTrace Logo

IV Iron for the Anemia of Traumatic Critical Illness

NCT01180894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-02-05

Study results available
· View outcomes & findings →

Summary

The purpose of this clinical trial is to determine whether intravenous iron supplementation of anemic, critically ill trauma patients improves anemia and reduces the need for a red blood cell transfusion.

Conditions

Interventions

DRUG

Iron sucrose

100 mg IV TIW

DRUG

Placebo

Sponsors & Collaborators

  • National Trauma Research Institute

    collaborator OTHER

  • Denver Health and Hospital Authority

    lead OTHER

Principal Investigators

  • Fredric M Pieracci, MD, MPH · Denver Health Medical Center, University of Colorado Health Science Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01180894 on ClinicalTrials.gov